titanium alloys in orthopaedics
titanium alloys orthopaedic implants properties
Bailey and Love's Short Practice of Surgery 28th Edition
Page 579
titanium implant osseointegration biocompatibility corrosion
Management of Upper Limb Amputation Rehabilitation (ULA)
Page 80
| Alloy | Composition | Common Application |
|---|---|---|
| CP-Ti (Grade 1–4) | Commercially pure titanium | Dental, screws, plates |
| Ti-6Al-4V (Grade 5) | Ti + 6% Aluminium + 4% Vanadium | Femoral stems, tibial trays, hip cups |
| Ti-6Al-7Nb | Ti + 6% Al + 7% Niobium | Alternative to Ti-6Al-4V (less cytotoxic) |
| Ti-12Mo-6Zr-2Fe (TMZF) | Beta-titanium | Intramedullary nails, spinal rods |
| Ti-13Nb-13Zr | Beta-titanium | Low-modulus applications |
| Ti-35Nb-7Zr-5Ta | Beta-titanium | Experimental low-stiffness implants |
| Technique | Effect |
|---|---|
| Sandblasting + acid etching (SLA) | Increased surface roughness → bone ingrowth |
| Hydroxyapatite (HA) coating | Accelerates osseointegration |
| Titanium plasma spray (TPS) | Porous surface for bone ingrowth |
| Anodization | Thickened oxide layer, colour-coding |
| Silver/antibiotic coating | Reduces periprosthetic infection |
| 3D-printed porous structures | Trabecular-like scaffolds for optimal bone ingrowth |
| Issue | Detail |
|---|---|
| Poor wear resistance | Not suitable as a bearing surface — debris causes osteolysis |
| Stress shielding | Modulus still higher than bone (less so with beta-Ti alloys) |
| Fretting corrosion | Modular junctions susceptible to fretting and mechanically assisted crevice corrosion |
| Notch sensitivity | Titanium alloys are sensitive to surface defects under cyclic loading |
| Cost | More expensive to manufacture than stainless steel |
| Vanadium toxicity | Ti-6Al-4V releases vanadium ions — newer alloys (Ti-6Al-7Nb) mitigate this |
| Property | Titanium (Ti-6Al-4V) | Cobalt-Chrome | Stainless Steel 316L |
|---|---|---|---|
| Density (g/cm³) | 4.4 | 8.3 | 7.9 |
| Elastic modulus (GPa) | ~110 | ~210 | ~200 |
| Yield strength (MPa) | ~900 | ~450–1000 | ~170–750 |
| Corrosion resistance | Excellent | Very good | Good |
| Wear resistance | Poor | Excellent | Good |
| MRI artefact | Minimal | Moderate | Significant |
| Biocompatibility | Excellent | Good | Good |
| Osseointegration | Excellent | Moderate | Poor |
give content on titaium and biological interfere in orthopaedics
titanium implant biological response bone interface osseointegration
Rehabilitation of Lower Limb Amputation
Page 32
titanium corrosion ion release tissue reaction orthopaedic implant
Bailey and Love's Short Practice of Surgery 28th Edition
Page 579
| Factor | Influence |
|---|---|
| Surface roughness | Rough/porous surfaces (Ra 1–2 µm) increase bone-to-implant contact area |
| Surface chemistry | TiO₂ chemistry promotes osteoblast attachment and mineralisation |
| Surface wettability | Hydrophilic surfaces enhance protein adsorption and cell spreading |
| Implant stability | Primary mechanical stability essential during early healing phase |
| Biological milieu | Host bone quality, vascularity, systemic disease (e.g., diabetes, osteoporosis) |
| Surgical technique | Atraumatic preparation, avoiding overheating (>47°C causes thermal necrosis) |
| Effect | Mechanism |
|---|---|
| Macrophage activation | Titanium particles phagocytosed → NF-κB pathway → pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) |
| Osteoclast stimulation | TNF-α and IL-1β upregulate RANKL → osteoclastogenesis → periprosthetic osteolysis |
| Fibrous tissue formation | Chronic inflammation → fibroblast proliferation → fibrous membrane at bone-implant interface |
| Aseptic loosening | Osteolysis + fibrous membrane formation → implant loosening without infection |
| Genotoxicity | High local concentrations of Ti, Al, and V ions cause DNA strand breaks in vitro |
| Systemic distribution | Titanium ions detected in serum, urine, liver, spleen, and regional lymph nodes |
| Allergic/hypersensitivity | Rare; type IV delayed hypersensitivity reported with titanium, more commonly with Al/V components |
| Host Factor | Effect on Titanium Interface |
|---|---|
| Osteoporosis | Reduced bone stock → impaired osseointegration |
| Diabetes mellitus | Impaired vascular supply and cellular response → delayed osseointegration, higher infection risk |
| Immunosuppression | Altered macrophage/lymphocyte function → impaired healing |
| Smoking | Vasoconstriction and oxidative stress → poor bone healing |
| Ageing | Reduced osteoblast activity and angiogenesis |
| Systemic infection/sepsis | Risk of haematogenous seeding of implant |
| Metal sensitivity | Rare hypersensitivity to Al/V components — Ti-6Al-7Nb preferred |
| Modification | Biological Goal |
|---|---|
| Sandblasting + acid etching (SLA) | Roughened microtopography → increased osteoblast attachment |
| Hydroxyapatite (HA) coating | Mimics bone mineral → accelerates early osseointegration |
| Anodisation | Controlled TiO₂ nanotopography → enhanced protein adsorption |
| UV photofunctionalisation | Removes hydrocarbon contamination → superhydrophilic surface → rapid protein adsorption |
| Nanostructured surfaces | Nanotube/nanorod arrays → contact guidance of osteoblasts |
| Silver/antibiotic coating | Reduces biofilm formation and periprosthetic infection |
| RGD peptide functionalisation | Direct integrin binding → faster cell adhesion |
| 3D-printed porous titanium | Trabecular-like scaffolds → bone ingrowth into implant volume |
| Interface | Key Biology | Clinical Outcome |
|---|---|---|
| Ti–Bone | Osseointegration, contact osteogenesis | Stable fixation, long-term function |
| Ti–Protein | Immediate adsorption of fibronectin, vitronectin | Determines cell adhesion and inflammation |
| Ti–Macrophage | Frustrated phagocytosis, M1→M2 transition | Controlled inflammation → healing |
| Ti–Osteoblast | Integrin-mediated adhesion, mineralisation | Bone formation at implant surface |
| Ti–Soft Tissue | Fibrous encapsulation or direct tissue integration | Aseptic loosening vs stable soft tissue seal |
| Ti–Bacteria | Biofilm formation on protein-coated surface | Periprosthetic infection |
| Ti–Ion Release | RANKL-mediated osteolysis, systemic distribution | Osteolysis, aseptic loosening |